MX2023006038A - Vacunas contra el virus del papiloma humano y usos de estas para enfermedades asociadas a hpv. - Google Patents
Vacunas contra el virus del papiloma humano y usos de estas para enfermedades asociadas a hpv.Info
- Publication number
- MX2023006038A MX2023006038A MX2023006038A MX2023006038A MX2023006038A MX 2023006038 A MX2023006038 A MX 2023006038A MX 2023006038 A MX2023006038 A MX 2023006038A MX 2023006038 A MX2023006038 A MX 2023006038A MX 2023006038 A MX2023006038 A MX 2023006038A
- Authority
- MX
- Mexico
- Prior art keywords
- hpv
- diseases associated
- human papillomavirus
- vaccines against
- pathologies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063118222P | 2020-11-25 | 2020-11-25 | |
| PCT/US2021/060605 WO2022115470A1 (en) | 2020-11-25 | 2021-11-23 | Human papilloma virus vaccines and uses of the same for hpv associated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023006038A true MX2023006038A (es) | 2023-07-11 |
Family
ID=81754898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023006038A MX2023006038A (es) | 2020-11-25 | 2021-11-23 | Vacunas contra el virus del papiloma humano y usos de estas para enfermedades asociadas a hpv. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240173396A1 (https=) |
| EP (1) | EP4251278A4 (https=) |
| JP (1) | JP2023550480A (https=) |
| KR (1) | KR20230113331A (https=) |
| CN (1) | CN117203342A (https=) |
| AU (1) | AU2021385551A1 (https=) |
| CA (1) | CA3197920A1 (https=) |
| IL (1) | IL303113A (https=) |
| MX (1) | MX2023006038A (https=) |
| WO (1) | WO2022115470A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121752584A (zh) * | 2023-05-22 | 2026-03-27 | 普瑞赛格恩公司 | 用于治疗复发性呼吸道乳头状瘤病的新型腺病毒疫苗疗法 |
| EP4716549A2 (en) * | 2023-05-22 | 2026-04-01 | Precigen, Inc. | T cell receptors generated as a result of hpv vaccine therapy and methods of treating patients with same |
| CN117965634B (zh) * | 2024-04-01 | 2024-07-12 | 北京唯源立康生物科技股份有限公司 | 一种hsv-1病毒载体及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN443995A0 (en) * | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
| US6225289B1 (en) | 1998-12-10 | 2001-05-01 | Genvec, Inc. | Methods and compositions for preserving adenoviral vectors |
| ES2276948T3 (es) * | 2001-08-23 | 2007-07-01 | MERCK & CO., INC. | Ensayos pcr de hp multiplex fluorescente que usan fluoforos multiples. |
| GB0222953D0 (en) * | 2002-10-03 | 2002-11-13 | Glaxo Group Ltd | Novel Compounds |
| AU2005222776A1 (en) * | 2003-12-31 | 2005-09-29 | Genimmune N.V. | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| US9050287B2 (en) * | 2009-01-23 | 2015-06-09 | The Trustees Of The University Of Pennsylvania | Vaccines for human papilloma virus and methods for using the same |
| MX360449B (es) * | 2011-10-12 | 2018-11-01 | Univ Pennsylvania | Vacunas para el virus del papiloma humano y metodos para su uso. |
| WO2018060288A1 (en) * | 2016-09-29 | 2018-04-05 | Glaxosmithkline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| KR102222582B1 (ko) * | 2018-02-02 | 2021-03-04 | 주식회사 에스엘백시젠 | 신규 다가 hpv 백신 조성물 |
| KR20250136930A (ko) * | 2018-03-06 | 2025-09-16 | 프레시전 인코포레이티드 | 사람 파필로마바이러스 백신 및 이의 용도 |
-
2021
- 2021-11-23 JP JP2023530809A patent/JP2023550480A/ja active Pending
- 2021-11-23 CA CA3197920A patent/CA3197920A1/en active Pending
- 2021-11-23 EP EP21899044.8A patent/EP4251278A4/en active Pending
- 2021-11-23 AU AU2021385551A patent/AU2021385551A1/en active Pending
- 2021-11-23 IL IL303113A patent/IL303113A/en unknown
- 2021-11-23 MX MX2023006038A patent/MX2023006038A/es unknown
- 2021-11-23 KR KR1020237020302A patent/KR20230113331A/ko active Pending
- 2021-11-23 US US18/253,624 patent/US20240173396A1/en active Pending
- 2021-11-23 CN CN202180089584.2A patent/CN117203342A/zh active Pending
- 2021-11-23 WO PCT/US2021/060605 patent/WO2022115470A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021385551A1 (en) | 2023-06-22 |
| WO2022115470A1 (en) | 2022-06-02 |
| IL303113A (en) | 2023-07-01 |
| KR20230113331A (ko) | 2023-07-28 |
| CN117203342A (zh) | 2023-12-08 |
| CA3197920A1 (en) | 2022-06-02 |
| US20240173396A1 (en) | 2024-05-30 |
| JP2023550480A (ja) | 2023-12-01 |
| EP4251278A4 (en) | 2025-09-03 |
| EP4251278A1 (en) | 2023-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023006038A (es) | Vacunas contra el virus del papiloma humano y usos de estas para enfermedades asociadas a hpv. | |
| MX2018014694A (es) | Terapia ultravioleta interna. | |
| PY2126530A (es) | VACUNA INACTIVADA CONTRA EL VIRUS DEL SARS-CoV-2 | |
| MD20150031A2 (ro) | Dispozitiv hiperbaric şi metode de producere a vaccinurilor inactivate şi proteinelor recombinante repliate/solubilizate | |
| CO2022017989A2 (es) | Vacunas para la papilomatosis respiratoria recurrente y métodos para usar estas | |
| MX2016016836A (es) | Metodos y dispositivos para tratar trastornos oculares posteriores. | |
| CL2021002582A1 (es) | Vacunas contra el circovirus porcino tipo 3 (pcv3), su producción y usos | |
| MX340770B (es) | Desempeñador de interfaz de paciente. | |
| WO2021156404A3 (en) | Treatment of hpv-related diseases | |
| PH12016502529B1 (en) | Influenza vaccine nasal vaccination system | |
| MX391627B (es) | Aplicación cuantitativa periorbital de fármacos oftalmológicos. | |
| CO2022011392A2 (es) | Vacuna contra hpv | |
| MX2018003528A (es) | Tratamiento de conjuntivitis viral utilizando ranpirnasa y/o anfinasa. | |
| Ritch et al. | Exfoliation syndrome and exfoliative glaucoma | |
| BR112022009421A2 (pt) | Regimes de dosagem para vacinas | |
| RU2008142140A (ru) | Противотуберкулезная вакцина | |
| MX2022012447A (es) | Vacuna inactivada contra el virus sars-cov-2. | |
| MX2022010781A (es) | Vacuna contra el virus sars-cov-2 con adyuvante cpg. | |
| MX2025013955A (es) | Vacunas contra el virus del papiloma humano y usos de las mismas | |
| CL2018002438A1 (es) | Método y composición para el tratamiento del cáncer o una lesión de la piel utilizando una vacuna. | |
| MX2021001288A (es) | Vacunacion con microvesiculas derivadas de celulas tumorales para tratamiento de cancer. | |
| MX2025013954A (es) | Nueva terapia de vacuna de adenovirus para el tratamiento de papilomatosis respiratoria recurrente | |
| NZ580603A (en) | Intradermal influenza vaccine | |
| AR074485A1 (es) | Vacuna contra lesiones neoplasicas o cancerosas causadas por el virus del papiloma humano (vph), procedimientos, usos y metodos | |
| NZ713490A (en) | Oral suspension for treating eosinophilic esophagitis |